Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.726 | Early Prognostication of Risk of Curve Progression using an Unsupervised Machine Learning Algorithm for Bone Microarchitecture Phenotyping – A Longitudinal Study on Mild Adolescent Idiopathic Scoliosis from First Presentation to Final Clinical Outcome | Dr. LAU Adam Yiu Chung |
| 2024.244 | Can Early Nighttime Bracing Prevent High Risk Mild Curve Progressing to Fulltime Bracing in Skeletally Immature Adolescent Idiopathic Scoliosis – A Pilot Feasibility Study | Dr. LAU Adam Yiu Chung |
| 2025.562 | Role of Bone Health Assessments Before Paediatric Spine Deformity Surgery | Dr. LAU Adam Yiu Chung |
| 2014.178 | Mast cells activities and osteoporosis - a novel research platform for the study of interaction of herbal and western anti-osteoporosis agents in human | Prof. LAU Alaster Hang Yung |
| 2015.375 | Comparative study on the effects of morphine on human connective and mucosal mast cells |
Prof. LAU Alaster Hang Yung 劉行榕 |
| 2016.421 | Identification of Genomic Biomarkers in Human Mast Cells |
Prof. LAU Alaster Hang Yung 劉行榕 |
| 2014.061 | Modulation of human mast cell functions by hydrogen sulphide | Prof. LAU Alaster Hang Yung |
| 2013.492 | Prevalence of anti-JC virus antibody in a cohort of Chinese patients with relpasing-remitting multiple sclerosis in Hong Kong | Dr. LAU Alexander Yuk Lun |
| 2016.040 | A retrospective analysis of a pilot program “Yan Oi Tong - CUHK Traditional Chinese Medicine Music Therapy Pilot Programme” |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2015.709 | An Observational Study to Evaluate Integrative Medicine in Managing Fatigue and Cognitive Deficits Associated with Multiple Sclerosis and Neuromyelitis Optica |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2017.453 | Outcome prediction of unstructured computed tomography brain imaging of intracerebral hemorrhage |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2017.528 | Efficacy and safety of Chinese Medicine Angong Niuhuang Wan for the Treatment of the Stroke: A Randomized, Double-blind,Placebo Controlled Clinical Trial |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2014.463 | A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders | Dr. LAU Alexander Yuk Lun |
| 2016.308 | A retrospective study aiming to explore the disease course, clinical features, electrodiagnostic and laboratory findings of cases with positive Anti-gangliosides antibodies |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2016.180 | Feasibility of Integrated Large Artery Occlusive Disease Assessment in Acute Ischemic Stroke to Identify Patients with High Risk of Recurrent Stroke and Poor Outcome (FLOW) |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2017.445 | International NMO Genetics Consortium: A Genome-wide Approach for Studying Disease Aetiology |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2016.094 | Quantitative Assessment of Tongue and Pulse Diagnosis for Integrative Chinese and Western Medicine Practice. |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2016.304 | Circadian clock as a novel therapeutic target for multiple sclerosis |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2021.620 | Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson’s disease: a pilot add-on, randomised, controlled, pragmatic clinical trial | Dr. LAU Alexander Yuk Lun |
| 2018.450 | Fatigue and Immunomodulatory Responses in Multiple Sclerosis with Integrative Medicine (FIRST) |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2020.449 | A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2020.456 | A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio®) in participants with relapsing forms of multiple sclerosis (GEMINI 1) |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2019.679 | A RANDOMIZED, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF ROZANOLIXIZUMAB IN ADULT PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2017.588 | Does surgery reduce mortality in patients with a cerebellar ICH? Observations from an international, multicentre, pooled data set. |
Dr. LAU Alexander Yuk Lun 劉玉麟 |
| 2019.595 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN ADULT PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2014.055 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZUMAB IN PATIENTS WITH RELAPSING NEUROMYELITIS OPTICA (NMO) | Dr. LAU Alexander Yuk Lun |
| 2014.028 | A Phase III, Open-Label, Extension Trial of ECU-NMO-301 to Evaluate the Safety and Efficacy of Eculizumab in Patients with Relapsing Neuromyelitis Optica (NMO) | Dr. LAU Alexander Yuk Lun |
| 2013.350 | Long-term, prospective, non-interventional, multinational, parallel-cohort study monitoring safety in patients with MS recently initiated with fingolimod once daily or treated with another approved disease-modifying therapy | Dr. LAU Alexander Yuk Lun |
| 2012.143 | Neutralizing antibodies to interferon-beta therapy in Chinese multiple sclerosis patients | Dr. LAU Alexander Yuk Lun |
| 2018.098 | A pilot study to observe and investigate the effect of cerebral perfusion by acupuncture in patients with cerebral small vessel disease |
Prof. LAU Alexander Yuk Lun 劉玉麟 |
| 2013.622 | The Multi-National Gilenya_ Pregnancy Exposure Registry in Multiple Sclerosis | Dr. Lau Alexander Yuk-lun |
| 2014.452 | MSBase: An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis (MS) | Dr. LAU Alexander Yuk-lun |
| 2011.505 | Outcome of acute stroke and patients who received intravenous thrombolysis | Dr. LAU Alexandra Yuk Lun |
| 2011.504 | Retrospective study of collateral circulation assessment in patients with symptomatic intractranial atherosclerosis | Dr. LAU Alexandra Yuk Lun |
| 2009.268 | Case control study on the aberrant expression of microRNAs and their predicated target genes in cervical intraepithelial neoplasm | Dr. LAU Amy Pui Kei |
| 2005.205 | Ethical Attitudes of Intensive Care Unit Nurses in Hong Kong Regarding Limitation of Life Support Therapy | LAU Angela Mei Te |
| 2009.130 | Randomized clinical trial on the efficacy of hydrotherapy incorporating Tai Chi and Ai Chi (Water Tai Chi) for patients with low back pain: a pilot study | Mr. Lau Anthony Wing Keung |
| 2018.258 | Effect of Martial-art training on physical functions, balance level, fatigue level, health-related quality of life, and biomarkers in prostate cancer survivors |
Mr. LAU Benjamin Ka Ki 柳家祺 |
| 2016.306 | A Prospective Pilot Study to Evaluate Pharmacists’ Intervention on Inappropriate Prescribing and Polypharmacy in geriatric patients in Inpatient Setting of Tai Po Hospital | Miss LAU Cherry Yuen Kiu |
| 2023.429 | Feasibility of Smart Glass Facilitated Remote Supervision in Intensive Care Unit- A Simulation Study | Dr. LAU Chi Ho |
| 2021.308 | Validation on the Screen for Cognitive Impairment in Psychiatry- Hong Kong Version (SCIP-HK Version) - Phase III |
Ms. LAU Ching Man 劉靖雯 |
| 2019.593 | A Retrospective Study of Computer-assisted Cognitive Training Program (CCTP) for psychiatric patients with Severe Mental Illness (SMI) |
Ms. LAU Ching Man 劉靖雯 |
| 2013.212 | Impact of Brown Bag Review on Drug-Related Problems in a Local Hospital Setting: A Randomized Controlled Study | Ms Lau Cho Kwan |
| 2014.046 | Effect of gait plate on gait pattern of in-toeing pediatric patients. | Mr. LAU Chun Kit |
| 2012.516 | Cross-sectional Study of Determinatns Predicting Food Label Use among Chinese Patients with Chronic Disease in a Private Hospital | Dr. Lau Chun Yin Victor |
| 2019.569 | Can TM4SF3 be used as novel prognostic marker and Andrographis paniculata as personalised therapy for metastatic esophageal cancer patients? |
Prof. LAU Clara Bik San 劉碧珊 |
| 2015.309 | Preclinical evaluation of the anti-tumor and anti-metastatic activities of Chinese herbal medicines using esophageal cancer patients-derived tumor tissues |
Prof. LAU Clara Bik San 劉碧珊 |
| 2016.444 | Beneficial efficacy of combined therapy using turmeric and chemotherapeutics in colorectal cancer – a final proof prior to clinical trial |
Prof. LAU Clara Bik San 劉碧珊 |
| 2017.567 | A pharmacokinetic study of simvastatin with Cistanches Herba – a final step to support their combined use in patients with statin-induced muscle toxicity. |
Prof. LAU Clara Bik San 劉碧珊 |
| 2015.305 | Use of colorectal cancer patients-derived tumor tissues in preclinical models of colorectal cancer for investigation of the anti-tumor and anti-metastatic activities of Chinese herbal medicines |
Prof. LAU Clara Bik San 劉碧珊 |
Page 133 of 289.